Multisystemic Long-Term Sequelae of Covid-19: A Review Based on the Current Literature Over a Year of Pandemic Experience


ŞAHİN A. R. , Kocyigit B. F. , Aksu E., Akkok B., Tasdogan A. M. , Sahin M., ...More

EURASIAN JOURNAL OF MEDICINE AND ONCOLOGY, vol.5, no.1, pp.6-26, 2021 (Journal Indexed in ESCI) identifier

  • Publication Type: Article / Review
  • Volume: 5 Issue: 1
  • Publication Date: 2021
  • Doi Number: 10.14744/ejmo.2021.69960
  • Title of Journal : EURASIAN JOURNAL OF MEDICINE AND ONCOLOGY
  • Page Numbers: pp.6-26

Abstract

On January 7, 2020, it was announced that the Chinese Government isolated a new variant of Coronavirus (SARS CoV-2). Officials reported that populations were not equally affected in terms of the number of cases, severe illness, and death. As of 28 December 2020, 81,000,000 cases have been confirmed globally, and approximately 1,770,000 total deaths have been reported for COVID-19. Besides difficulties of COVID-19 management in the acute stage, long-term consequences of the infection could cause widespread public health problems across the World. This review article aims to examine current literature regarding COVID-19, identify post-illness sequelae, detect patients at risk for sequelae, and provide guidance to management strategies. In the report, long-term pulmonary sequels and systemic problems including cardiovascular, neurological, psychiatric, endocrinologic, nephrological, hematologic, gastrointestinal, dermatologic, etc. of COVID-19 are discussed in accordance with recent scientific publications.